Domů › Kolorektální karcinom › Kalifornie › Orange
Klinické studie Kolorektální karcinom v Orange, CA
16 studií pro Kolorektální karcinom hledá účastníky v lokalitách v Orange a okolí (do cca 30 mil). Otevřete studii a zjistěte, kdo se může zapojit a jak kontaktovat tým studie.
Oficiální text studie (anglicky)
Hledáte účastníky pro studii? Zvýrazněte ji nahoře na této stránce – $99 na 30 dní →
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial
Probíhá náborFáze 2
- UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
Probíhá náborFáze 1/2
- University of California Irvine, Orange
Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable Cancers
Probíhá náborFáze 1
- UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange
Testing the Addition of Anti-cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment, Cetuximab Plus Encorafenib, for Colorectal Cancer
Probíhá náborFáze 1
- UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
Probíhá náborFáze 2/3
- University of California, Irvine (UCI) Health - UC Irvine Medical Center, Orange
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Probíhá náborFáze 1/2
- UC IRVINE Health, Orange
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
Probíhá náborFáze 3
- Clinical Study Site, Orange
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Probíhá náborFáze 1/2
- Children's Hospital of Orange County, Orange
Testing the Addition of an Anti-Cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (5-Fluorouracil) for Metastatic, Refractory Colorectal Cancer
Probíhá náborFáze 1
- UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange
Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness
Probíhá náborFáze 1/2
- UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange
Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial
Probíhá náborFáze 2
- Chao Family Comprehensive Cancer Center, University of California Irvine, Orange
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
Probíhá náborFáze 1/2
- UC Irvine/Chao Family Comprehensive Cancer Center, Orange
Study of ctDNA Guided Change in Tx for Refractory Minimal Residual Disease in Colon Adenocarcinomas
Probíhá náborFáze 1
- Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange
TATE and Pembrolizumab (MK3475) in mCRC and NSCLC
Probíhá náborFáze 2
- University of California, Irvine Medical Center, Orange
Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot Trial
Probíhá náborFáze 2
- Chao Family Comprehensive Cancer Center, University of California Irvine, Orange
64Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract Cancer
Probíhá náborFáze 1/2
- UC Irvine Health - Chao Family Comprehensive Cancer Center, Orange
Studie Kolorektální karcinom v jiných městech
- Houston, TX102 studií
- New York City, NY78 studií
- Nashville, TN69 studií
- Boston, MA63 studií
- Los Angeles, CA59 studií
- Arlington, VA52 studií
- St. Louis, MO50 studií
- San Antonio, TX46 studií
- Philadelphia, PA44 studií
- Grand Rapids, MI40 studií
- Baldwin Park, CA37 studií
- Chicago, IL34 studií
Další studie v Orange
- Nemalobuněčný plicní karcinom25 studií
- Metastatický karcinom20 studií
- Rakovina vaječníků16 studií
- Rakovina slinivky břišní15 studií
- Melanom14 studií
- Rakovina jater (hepatocelulární karcinom)14 studií
- Rakovina prsu14 studií
- Rakovina plic14 studií
- Rakovina prostaty14 studií
- Rakovina žaludku13 studií
- Rakovina (všechny typy)13 studií
- Akutní myeloidní leukemie13 studií
Zdroj: ClinicalTrials.gov, data načtena 6. 10. 2026. Každá studie má vlastní kritéria způsobilosti; o účasti rozhoduje tým studie.